The pharmaceutical industry was a hot topic in the blogosphere this week:
Cervantes at Stayin’ Alive advocates for a ban on direct-to-consumer pharmaceutical advertising (as opposed to the proposed legislation likely to come from the pharma industry).
Orac at Respectful Insolence has a different take on the “DCA is a miracle cancer drug Big Pharma doesn’t want you to know about” idea that’s spreading through the blogosphere.
Andrew Leonard at How the World Works knows what will make your sympathy for Big Pharma disappear.
And, of course, there were plenty of interesting posts on other topics:
Janet Stemwedel at Adventures in Ethics and Science comments on Nature’s recent article about scientific fraud investigations.
Jessica Gottlieb at Global Health Policy directs our attention to the millions of lives saved by eliminating measles.
Robert McClure at Dateline Earth has the latest on the Federal Way school district’s Inconvenient Truth moratorium, and he provides additional info that didn’t make it into his story on EPA library closures.
Tara Smith at Aetiology reminds us that Angola is still suffering from cholera outbreak.
Geoff Davis at PhDs.org asks his visitors how they’d address the issue of plummeting approval rates for NIH and NSF grant applications.
Corie Lok at Nature Network Boston reports on publishers fighting open access and correcting misperceptions about “gay sheep” research.
Gristmill checks up on the supposed non-problem of mercury in fish.
What else is worth a read? Leave suggestions in the comments.